| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.3 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |